ARTICLE | Clinical News
HercepTest regulatory update
November 1, 2010 7:00 AM UTC
FDA approved an expanded label for Dako's HercepTest to identify HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma patients who are appropriate for treatment with Herceptin...